0001213900-16-014819.txt : 20160708 0001213900-16-014819.hdr.sgml : 20160708 20160707174854 ACCESSION NUMBER: 0001213900-16-014819 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160708 DATE AS OF CHANGE: 20160707 EFFECTIVENESS DATE: 20160708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Icagen, Inc. CENTRAL INDEX KEY: 0001518520 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 200982060 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-266588 FILM NUMBER: 161757366 BUSINESS ADDRESS: STREET 1: 4222 EMPEROR BLVD., SUITE 350 STREET 2: RESEARCH TRIANGLE PARK CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-941-5206 MAIL ADDRESS: STREET 1: 4222 EMPEROR BLVD., SUITE 350 STREET 2: RESEARCH TRIANGLE PARK CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: XRpro Sciences, Inc. DATE OF NAME CHANGE: 20141204 FORMER COMPANY: FORMER CONFORMED NAME: Caldera Pharmaceuticals Inc DATE OF NAME CHANGE: 20110419 D 1 primary_doc.xml X0707 D LIVE 0001518520 Icagen, Inc. 4222 EMPEROR BLVD., SUITE 350 DURHAM NC NORTH CAROLINA 27703 (919) 941-5206 DELAWARE None XRpro Sciences, Inc. Caldera Pharmaceuticals Inc Corporation true Richard Cunningham 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Executive Officer Benjamin Warner 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Director Timothy Tyson 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Director Michael Taglich 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Director Mark Korb 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Executive Officer Vincent Palmieri 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Director Clive Kabatznik 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Director Edward Roffman 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Director Douglas Krafte 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2016-06-27 false true true false 10000 Taglich Brothers, Inc. 29102 None None 275 MADISON AVENUE SUITE 1618 NEW YORK NY NEW YORK 10016 CA CALIFORNIA FL FLORIDA KS KANSAS MI MICHIGAN NY NEW YORK false 1145000 1145000 0 *The amount being raised was a minimum of $1,000,000 false 12 68700 true 0 true 0 true false Icagen, Inc. /s/ Richard Cunningham Richard Cunningham Chief Executive Officer 2016-07-07